CANNAPHARMARX, INC. (CPMD) Free cash flow 2016–2025
CANNAPHARMARX, INC. (CPMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$794,621FY2025 · since FY2016: -$22,380 → -$794,621
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$794,621 | +53.2% |
| FY2024 | -$1.7M | +27.9% |
| FY2023 | -$2.4M | -50.5% |
| FY2022 | -$1.6M | +35.4% |
| FY2021 | -$2.4M | -329.6% |
| FY2020 | -$563,573 | +85.2% |
| FY2019 | -$3.8M | -303.7% |
| FY2018 | -$941,136 | — |
| FY2016 | -$22,380 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPMD financial trends
CPMD RevenueCPMD Net incomeCPMD Net marginCPMD Gross profitCPMD Gross marginCPMD Operating incomeCPMD Operating marginCPMD Operating cash flowCPMD Capital expendituresCPMD Return on equityCPMD Stock buybacksCPMD Dividends paidCPMD Total assetsCPMD Total liabilitiesCPMD Shareholders’ equityCPMD overview →